10 Best Stocks Under $15 To Buy Now

Page 8 of 8

1. Roivant Sciences Ltd. (NASDAQ:ROIV)

Number of Hedge Fund Holders: 62

Share Price as of the close of September 27: $11.48

Roivant Sciences Ltd. (NASDAQ:ROIV) is a healthcare company focused on developing innovative medicines and technologies to treat patients. It is the best stock under $15 to buy now, with 62 hedge funds having investments in the company, according to Insider Monkey’s database, as of Q2 2024.

The company showcased substantial business growth and advancements in its latest earnings call for Q1 FY25. Some of the key takeaways from the quarter included $18.4 million in product revenue for VTAMA, with prescription volumes up 20% year-over-year. The company is also anticipating approvals for the launch of VTAMA in atopic dermatitis by the end of the year.

Roivant Sciences Ltd. (NASDAQ:ROIV) also enrolled for the Phase 3 study of Brepocitinib in dermatomyositis in Q2. This is a drug that treats plaque psoriasis. Results of the study are expected during the second half of the year. Moreover, the first FcRn produced by the company has also yielded solid results, generating $1.2 billion in sales in the first year after its launch, indicating strong market demand.

Considering these factors, there is a general bullish sentiment around the stock, with consensus among Street analysts on its Strong Buy rating. They also anticipate a 52% spike in its share price compared to current levels over the next few months, expecting positive results from ongoing drug studies. There is some concern that operating costs may rise with the initiation of new trials, but the company ended Q2 strongly with $5.7 billion in cash and cash equivalents, reflecting a solid financial position.

In September this year, the company struck another hot deal, announcing the sale of its Dermavant subsidiary, along with VMATA treatment, to pharma company, Organon, for $1.2 billion. This amount is likely to help free up further cash for Roivant Sciences Ltd. (NASDAQ:ROIV) to meet its operating and research expenses associated with new drug trials.

Overall, ROIV ranks first among the 10 Best Stocks Under $15 To Buy Now. While we acknowledge the potential of ROIV as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than ROIV but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: $30 Trillion Opportunity: 15 Best Humanoid Robot Stocks to Buy According to Morgan Stanley and Jim Cramer Says NVIDIA ‘Has Become A Wasteland’.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

Page 8 of 8